Search Results Search Sort by RelevanceMost Recent AMA Code Says Aug 2016 AMA Code of Medical Ethics’ Opinions Applicable to Pathology Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics’ opinions related to pathology. AMA J Ethics. 2016;18(8):800-801. doi: 10.1001/journalofethics.2016.18.8.coet1-1608. Case and Commentary Aug 2003 Obesity as Medical Neglect: Should Doctors Report? David Collier, MD, PhD, Ronald M. Perkin, MD, MA, and Joseph R. Zanga, MD Virtual Mentor. 2003;5(8):308-311. doi: 10.1001/virtualmentor.2003.5.8.ccas3-0308. In the Literature Aug 2003 The Pediatrician's Role in Family Decision Making Susanna Smith Virtual Mentor. 2003;5(8):322-324. doi: 10.1001/virtualmentor.2003.5.8.jdsc2-0308. Policy Forum Aug 2003 The Ethics of Research with Children Timothy F. Murphy, PhD Virtual Mentor. 2003;5(8):333-335. doi: 10.1001/virtualmentor.2003.5.8.pfor2-0308. Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310. Health Law Oct 2003 In Defense of Absolute Confidentiality Kenneth Kipnis, PhD Virtual Mentor. 2003;5(10):449-454. doi: 10.1001/virtualmentor.2003.5.10.hlaw2-0310. State of the Art and Science Nov 2017 Social Media Channels in Health Care Research and Rising Ethical Issues Samy A. Azer, MD, PhD, MEd, MPH Using social media tools in health-related research involves challenges to confidentiality, privacy, and consent. AMA J Ethics. 2017;19(11):1061-1069. doi: 10.1001/journalofethics.2017.19.11.peer1-1711. Podcast Jul 2023 Author Interview: “How Should We Approach Body Size Diversity in Clinical Trials?” Dania Pagarkar joins Ethics Talk to discuss her article, coauthored with Drs Erin Harrop and Lisa Erlanger: “How Should We Approach Body Size Diversity in Clinical Trials?” Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777. State of the Art and Science Jul 2023 How Should We Approach Body Size Diversity in Clinical Trials? Dania Pagarkar, Erin Harrop, PhD, LICSW, and Lisa Erlanger, MD Despite concerns about clinical outcomes for patients with obesity, clinical trials report few data about such patients. AMA J Ethics. 2023;25(7):E517-527. doi: 10.1001/amajethics.2023.517. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page Next › Last page Last »
AMA Code Says Aug 2016 AMA Code of Medical Ethics’ Opinions Applicable to Pathology Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics’ opinions related to pathology. AMA J Ethics. 2016;18(8):800-801. doi: 10.1001/journalofethics.2016.18.8.coet1-1608.
Case and Commentary Aug 2003 Obesity as Medical Neglect: Should Doctors Report? David Collier, MD, PhD, Ronald M. Perkin, MD, MA, and Joseph R. Zanga, MD Virtual Mentor. 2003;5(8):308-311. doi: 10.1001/virtualmentor.2003.5.8.ccas3-0308.
In the Literature Aug 2003 The Pediatrician's Role in Family Decision Making Susanna Smith Virtual Mentor. 2003;5(8):322-324. doi: 10.1001/virtualmentor.2003.5.8.jdsc2-0308.
Policy Forum Aug 2003 The Ethics of Research with Children Timothy F. Murphy, PhD Virtual Mentor. 2003;5(8):333-335. doi: 10.1001/virtualmentor.2003.5.8.pfor2-0308.
Health Law Oct 2003 In Defense of Exceptions to Confidentiality Dudley Stewart, MD Virtual Mentor. 2003;5(10):445-448. doi: 10.1001/virtualmentor.2003.5.10.hlaw1-0310.
Health Law Oct 2003 In Defense of Absolute Confidentiality Kenneth Kipnis, PhD Virtual Mentor. 2003;5(10):449-454. doi: 10.1001/virtualmentor.2003.5.10.hlaw2-0310.
State of the Art and Science Nov 2017 Social Media Channels in Health Care Research and Rising Ethical Issues Samy A. Azer, MD, PhD, MEd, MPH Using social media tools in health-related research involves challenges to confidentiality, privacy, and consent. AMA J Ethics. 2017;19(11):1061-1069. doi: 10.1001/journalofethics.2017.19.11.peer1-1711.
Podcast Jul 2023 Author Interview: “How Should We Approach Body Size Diversity in Clinical Trials?” Dania Pagarkar joins Ethics Talk to discuss her article, coauthored with Drs Erin Harrop and Lisa Erlanger: “How Should We Approach Body Size Diversity in Clinical Trials?”
Medicine and Society Oct 2023 What Might Aducanumab Teach Us About Clinicians’ Judgment About Whether to Recommend Emerging Alzheimer’s Interventions? Adam W. Burroughs, MD and Lewis P. Krain, MD Ethics questions about care of patients with AD could influence clinicians’ judgment about whether and when to recommend aducanumab. AMA J Ethics. 2023;25(10):E777-782. doi: 10.1001/amajethics.2023.777.
State of the Art and Science Jul 2023 How Should We Approach Body Size Diversity in Clinical Trials? Dania Pagarkar, Erin Harrop, PhD, LICSW, and Lisa Erlanger, MD Despite concerns about clinical outcomes for patients with obesity, clinical trials report few data about such patients. AMA J Ethics. 2023;25(7):E517-527. doi: 10.1001/amajethics.2023.517.